1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diabetic Foot Ulcers Treatment Market
4. Market Overview
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Diabetic Foot Ulcers Treatment Market Value Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Epidemiology of Diabetic Ulcer (foot ulcer, corneal ulcer, skin ulcers, mouth ulcer, and others)
5.2. Regulatory and Reimbursement Scenario
5.3. Key Treatment of Diabetic Ulcer & Clinical Trials On Diabetic Foot Ulcers
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Diabetic Foot Ulcers Treatment Market Analysis, by Treatment Type
6.1. Introduction
6.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by Treatment Type
6.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by Treatment Type
6.4. Global Diabetic Foot Ulcers Treatment Market Analysis, by Treatment Type
6.5. Global Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
6.5.1. Wound Care Dressings
6.5.1.1. Antimicrobial Dressings
6.5.1.2. Foam Dressings
6.5.1.3. Film Dressings
6.5.1.4. Alginate Dressings
6.5.1.5. Hydrogel Dressings
6.5.1.6. Hydrocolloid Dressings
6.5.1.7. Collagen Dressings
6.5.2. Wound Care Devices
6.5.2.1. Negative Pressure Wound Therapy
6.5.2.2. Ultrasound Therapy
6.5.2.3. HBOT and PEMF Therapy
6.5.3. Active Therapies
6.5.3.1. Skin Grafts & Substitutes
6.5.3.2. Growth Factors
6.5.3.3. Hemostatic Agents & Sealants
6.5.4. Antibiotic Medications
6.5.5. Others
7. Global Diabetic Foot Ulcers Treatment Market Analysis, by Grade of Ulcer
7.1. Introduction
7.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by Grade of Ulcer
7.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by Grade of Ulcer
7.4. Global Diabetic Foot Ulcers Treatment Market Analysis, by Grade of Ulcer
7.5. Global Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
7.5.1. Grade 1
7.5.2. Grade 2
7.5.3. Grade 3
7.5.4. Grade 4
7.5.5. Grade 5
8. Global Diabetic Foot Ulcers Treatment Market Analysis, by Ulcer Type
8.1. Introduction
8.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by Ulcer Type
8.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by Ulcer Type
8.4. Global Diabetic Foot Ulcers Treatment Market Analysis, by Ulcer Type
8.5. Global Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
8.5.1. Neuropathic Ulcers
8.5.2. Ischemic Ulcers
8.5.3. Neuroischemic Ulcers
9. Global Diabetic Foot Ulcers Treatment Market Analysis, by End-user
9.1. Introduction
9.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by End-user
9.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by End-user
9.4. Global Diabetic Foot Ulcers Treatment Market Analysis, by End-user
9.5. Global Diabetic Foot Ulcers Treatment Market Forecast, by End-user
9.5.1. Hospital Inpatient Settings
9.5.2. Hospital Outpatient Settings
9.5.3. Community Health Centers
9.5.4. Home Healthcare
10. Global Diabetic Foot Ulcers Treatment Market Analysis, by Region
10.1. Introduction
10.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by Region
10.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by Region
10.4. Global Diabetic Foot Ulcers Treatment Market Forecast, by Region
10.4.1. North America
10.4.2. Europe
10.4.3. Asia Pacific
10.4.4. Latin America
10.4.5. Middle East & Africa
11. North America Diabetic Foot Ulcers Treatment Market Analysis
11.1. Key Insights: North America Diabetic Foot Ulcers Treatment Market
11.2. North America Diabetic Foot Ulcers Treatment Market Overview
11.3. North America Diabetic Foot Ulcers Treatment Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
11.5. North America Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
11.5.1. Wound Care Dressings
11.5.1.1. Antimicrobial Dressings
11.5.1.2. Foam Dressings
11.5.1.3. Film Dressings
11.5.1.4. Alginate Dressings
11.5.1.5. Hydrogel Dressings
11.5.1.6. Hydrocolloid Dressings
11.5.1.7. Collagen Dressings
11.5.2. Wound Care Devices
11.5.2.1. Negative Pressure Wound Therapy
11.5.2.2. Ultrasound Therapy
11.5.2.3. HBOT and PEMF Therapy
11.5.3. Active Therapies
11.5.3.1. Skin Grafts & Substitutes
11.5.3.2. Growth Factors
11.5.3.3. Hemostatic Agents & Sealants
11.5.4. Antibiotic Medications
11.5.5. Others
11.6. North America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
11.7. North America Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
11.7.1. Grade 1
11.7.2. Grade 2
11.7.3. Grade 3
11.7.4. Grade 4
11.7.5. Grade 5
11.8. North America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
11.9. North America Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
11.9.1. Neuropathic Ulcers
11.9.2. Ischemic Ulcers
11.9.3. Neuroischemic Ulcers
11.10. North America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
11.11. North America Diabetic Foot Ulcers Treatment Market Forecast, by End-user
11.11.1. Hospital Inpatient Settings
11.11.2. Hospital Outpatient Settings
11.11.3. Community Health Centers
11.11.4. Home Healthcare
12. Europe Diabetic Foot Ulcers Treatment Market Analysis
12.1. Key Insights: Europe Diabetic Foot Ulcers Treatment Market
12.2. Europe Diabetic Foot Ulcers Treatment Market Overview
12.3. Europe Diabetic Foot Ulcers Treatment Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. U.K.
12.3.3. France
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
12.5. Europe Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
12.5.1. Wound Care Dressings
12.5.1.1. Antimicrobial Dressings
12.5.1.2. Foam Dressings
12.5.1.3. Film Dressings
12.5.1.4. Alginate Dressings
12.5.1.5. Hydrogel Dressings
12.5.1.6. Hydrocolloid Dressings
12.5.1.7. Collagen Dressings
12.5.2. Wound Care Devices
12.5.2.1. Negative Pressure Wound Therapy
12.5.2.2. Ultrasound Therapy
12.5.2.3. HBOT and PEMF Therapy
12.5.3. Active Therapies
12.5.3.1. Skin Grafts & Substitutes
12.5.3.2. Growth Factors
12.5.3.3. Hemostatic Agents & Sealants
12.5.4. Antibiotic Medications
12.5.5. Others
12.6. Europe Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
12.7. Europe Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
12.7.1. Grade 1
12.7.2. Grade 2
12.7.3. Grade 3
12.7.4. Grade 4
12.7.5. Grade 5
12.8. Europe Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
12.9. Europe Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
12.9.1. Neuropathic Ulcers
12.9.2. Ischemic Ulcers
12.9.3. Neuroischemic Ulcers
12.10. Europe Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
12.11. Europe Diabetic Foot Ulcers Treatment Market Forecast, by End-user
12.11.1. Hospital Inpatient Settings
12.11.2. Hospital Outpatient Settings
12.11.3. Community Health Centers
12.11.4. Home Healthcare
13. Asia Pacific Diabetic Foot Ulcers Treatment Market Analysis
13.1. Key Insights: Asia Pacific Diabetic Foot Ulcers Treatment Market
13.2. Asia Pacific Diabetic Foot Ulcers Treatment Market Overview
13.3. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by Country/Sub-region
13.3.1. China
13.3.2. Japan
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
13.5. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
13.5.1. Wound Care Dressings
13.5.1.1. Antimicrobial Dressings
13.5.1.2. Foam Dressings
13.5.1.3. Film Dressings
13.5.1.4. Alginate Dressings
13.5.1.5. Hydrogel Dressings
13.5.1.6. Hydrocolloid Dressings
13.5.1.7. Collagen Dressings
13.5.2. Wound Care Devices
13.5.2.1. Negative Pressure Wound Therapy
13.5.2.2. Ultrasound Therapy
13.5.2.3. HBOT and PEMF Therapy
13.5.3. Active Therapies
13.5.3.1. Skin Grafts & Substitutes
13.5.3.2. Growth Factors
13.5.3.3. Hemostatic Agents & Sealants
13.5.4. Antibiotic Medications
13.5.5. Others
13.6. Asia Pacific Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
13.7. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
13.7.1. Grade 1
13.7.2. Grade 2
13.7.3. Grade 3
13.7.4. Grade 4
13.7.5. Grade 5
13.8. Asia Pacific Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
13.9. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
13.9.1. Neuropathic Ulcers
13.9.2. Ischemic Ulcers
13.9.3. Neuroischemic Ulcers
13.10. Asia Pacific Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
13.11. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by End-user
13.11.1. Hospital Inpatient Settings
13.11.2. Hospital Outpatient Settings
13.11.3. Community Health Centers
13.11.4. Home Healthcare
14. Latin America Diabetic Foot Ulcers Treatment Market Analysis
14.1. Key Insights: Latin America Diabetic Foot Ulcers Treatment Market
14.2. Latin America Diabetic Foot Ulcers Treatment Market Overview
14.3. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
14.5. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
14.5.1. Wound Care Dressings
14.5.1.1. Antimicrobial Dressings
14.5.1.2. Foam Dressings
14.5.1.3. Film Dressings
14.5.1.4. Alginate Dressings
14.5.1.5. Hydrogel Dressings
14.5.1.6. Hydrocolloid Dressings
14.5.1.7. Collagen Dressings
14.5.2. Wound Care Devices
14.5.2.1. Negative Pressure Wound Therapy
14.5.2.2. Ultrasound Therapy
14.5.2.3. HBOT and PEMF Therapy
14.5.3. Active Therapies
14.5.3.1. Skin Grafts & Substitutes
14.5.3.2. Growth Factors
14.5.3.3. Hemostatic Agents & Sealants
14.5.4. Antibiotic Medications
14.5.5. Others
14.6. Latin America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
14.7. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
14.7.1. Grade 1
14.7.2. Grade 2
14.7.3. Grade 3
14.7.4. Grade 4
14.7.5. Grade 5
14.8. Latin America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
14.9. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
14.9.1. Neuropathic Ulcers
14.9.2. Ischemic Ulcers
14.9.3. Neuroischemic Ulcers
14.10. Latin America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
14.11. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by End-user
14.11.1. Hospital Inpatient Settings
14.11.2. Hospital Outpatient Settings
14.11.3. Community Health Centers
14.11.4. Home Healthcare
15. Middle East & Africa Diabetic Foot Ulcers Treatment Market Analysis
15.1. Key Insights: Middle East & Africa Diabetic Foot Ulcers Treatment Market
15.2. Middle East & Africa Diabetic Foot Ulcers Treatment Market Overview
15.3. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
15.5. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
15.5.1. Wound Care Dressings
15.5.1.1. Antimicrobial Dressings
15.5.1.2. Foam Dressings
15.5.1.3. Film Dressings
15.5.1.4. Alginate Dressings
15.5.1.5. Hydrogel Dressings
15.5.1.6. Hydrocolloid Dressings
15.5.1.7. Collagen Dressings
15.5.2. Wound Care Devices
15.5.2.1. Negative Pressure Wound Therapy
15.5.2.2. Ultrasound Therapy
15.5.2.3. HBOT and PEMF Therapy
15.5.3. Active Therapies
15.5.3.1. Skin Grafts & Substitutes
15.5.3.2. Growth Factors
15.5.3.3. Hemostatic Agents & Sealants
15.5.4. Antibiotic Medications
15.5.5. Others
15.6. Middle East & Africa Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
15.7. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
15.7.1. Grade 1
15.7.2. Grade 2
15.7.3. Grade 3
15.7.4. Grade 4
15.7.5. Grade 5
15.8. Middle East & Africa Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
15.9. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
15.9.1. Neuropathic Ulcers
15.9.2. Ischemic Ulcers
15.9.3. Neuroischemic Ulcers
15.10. Middle East & Africa Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
15.11. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by End-user
15.11.1. Hospital Inpatient Settings
15.11.2. Hospital Outpatient Settings
15.11.3. Community Health Centers
15.11.4. Home Healthcare
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Convatec, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Integra LifeSciences Corporation
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. 3M Health Care
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Coloplast Corp.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Smith & Nephew Plc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. B. Braun Melsungen AG
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Medline Industries, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Organogenesis, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Mölnlycke Health Care
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. BSN medical GmbH
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Cardinal Health
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Orpyx Medical Technologies Inc.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. Compedica Holdings, Ltd.
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. Tissue Regenix
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer